Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Odyssey Health (ODYY) Cash & Equivalents (2016 - 2026)

Odyssey Health has reported Cash & Equivalents over the past 8 years, most recently at $72534.0 for Q3 2021.

  • For Q3 2021, Cash & Equivalents fell 86.97% year-over-year to $72534.0; the TTM value through Jul 2021 reached $72534.0, down 86.97%, while the annual FY2021 figure was $72534.0, 86.97% down from the prior year.
  • Cash & Equivalents for Q3 2021 was $72534.0 at Odyssey Health, down from $1.4 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.4 million in Q2 2021 and troughed at $328.0 in Q2 2019.
  • A 5-year average of $142436.4 and a median of $11529.0 in 2017 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 97.1% in 2018 and later soared 42744.87% in 2019.
  • Year by year, Cash & Equivalents stood at $11529.0 in 2017, then tumbled by 91.28% to $1005.0 in 2018, then surged by 10081.09% to $102320.0 in 2019, then soared by 186.12% to $292756.0 in 2020, then crashed by 75.22% to $72534.0 in 2021.
  • Business Quant data shows Cash & Equivalents for ODYY at $72534.0 in Q3 2021, $1.4 million in Q2 2021, and $63072.0 in Q1 2021.